Alternaria alternata

Alternaria alternata has been studied in 2 papers since 2019: none in people yet, 1 in animals, 1 review; 1 in the past year. The research so far is in animals. The newest paper, Jan 30, 2026: “Intestinal probiotic fungi improve PCOS by sensing metformin signaling and inhibiting gut derived ceramide levels”.

Intervention

2 papers study it2 findingsUpdated

See all 2 papers on alternaria alternata

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: National Natural Science Foundation of China and 1 more
  • Animals1

What did studies of alternaria alternata find?

2

Studies of alternaria alternata measured 2 outcomes: ovarian function and polycystic ovary syndrome.

Ovarian function

upin mice1

1 study
  1. Alternaria alternata improves ovarian function in mice (PCOS).

    “reducing ceramide levels and endoplasmic reticulum stress in granulosa cells to improve ovarian function”

    AnimalsPCOS

    Intestinal probiotic fungi improve PCOS by sensing metformin signaling and inhibiting gut derived ceramide levels

    Research SquarePreprint

Polycystic ovary syndrome

downin mice1

1 study
  1. Alternaria alternata decreases polycystic ovary syndrome in mice (PCOS).

    “Alternaria alternata (A. alternata) as a metformin-enriched gut fungus that alleviates PCOS in mice”

    AnimalsPCOS

    Intestinal probiotic fungi improve PCOS by sensing metformin signaling and inhibiting gut derived ceramide levels

    Research SquarePreprint

More on Polycystic ovary syndrome

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months